20:00:57 EST Sun 28 Feb 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Emerald Health Therapeutics Inc
Symbol EMH
Shares Issued 188,792,493
Close 2020-08-28 C$ 0.215
Recent Sedar Documents

Emerald Health launches SYNC 15 THC spray

2020-08-31 07:46 ET - News Release

Mr. Riaz Bandali reports

EMERALD HEALTH THERAPEUTICS LAUNCHES NEW FAST-ACTING CANNABIS SPRAY PRODUCTS OFFERING CONSUMERS SIGNIFICANTLY IMPROVED PREDICTABILITY AND CONTROL OF EFFECTS

Emerald Health Therapeutics Inc. has launched the first product in its adult-use SYNC nano fast-acting cannabis spray product line. SYNC 15 nano THC (tetrahydrocannabinol) fast action spray allows consumers to choose ingestion over inhalation of cannabis while achieving a much more rapid, predictable onset and shorter controlled duration of effects compared with edibles and oils. The sublingual spray's effects can start in 10 to 20 minutes and last two to four hours. Emerald has made the first product shipment to Alberta and Saskatchewan, with availability for purchase by consumers expected early this week.

SYNC 15 nano THC fast action spray contains 15 milligrams per millilitre of THC and all-natural citrus flavouring and limonene terpene that provide an enjoyable flavour. The terpene has also been scientifically demonstrated to impart a mellowing (anxiolytic) yet uplifting (anti-depressive) effect. The discreet, convenient and mess-free spray bottle allows for a high degree of control over the dosage, with approximately 1.5 mg of THC per activation, as well as easy storage and portability. The nanoemulsion product also requires a lower dose to achieve cannabis effects and can be a more economical product choice. Emerald is preparing for the launch of its second product, SYNC 15 nano CBD (cannabidiol) fast action spray, containing 15 mg/ml of CBD with natural lemon flavouring and limonene terpene.

"We looked carefully at unmet needs in the cannabis marketplace and applied our product development capabilities to create a product line with multiple points of consumer appeal," said Riaz Bandali, president and chief executive officer of Emerald. "With an emphasis on science-based innovation, we created this product line using proven nanoemulsion technology and are pleased to offer the benefits of this high performing technology to the cannabis industry."

The SYNC Nano products are formulated by Emerald using a proprietary process to achieve nano-sized droplets that bypass the digestive system due to their tiny size. This result significantly multiplies bioavailability and absorption of cannabinoids in the body compared with the normal path of ingestion of cannabis edibles and oils -- and also compared with conventional emulsion approaches. Nanoemulsions are currently being used safely in the drug delivery, pharmaceutical, cosmetic and food industries to improve the delivery and stability of ingredients.

About Emerald Health Therapeutics Inc.

Emerald Health is committed to creating new consumer experiences with distinct recreational-, medical- and wellness-oriented cannabis and non-cannabis products, with an emphasis on life-science-based innovation and production excellence. The company's three distinct operating assets are designed to uniquely serve the Canadian marketplace and international opportunities. These assets, all in full production, include: its greenhouse operation (78,000 square feet), based in metro Vancouver, B.C., capable of producing organic-certified product; Verdelite, its premium craft cannabis production indoor facility in St. Eustache, Que. (88,000 square feet), which the company has recently agreed to sell; and Pure Sunfarms, its 41.3-per-cent-owned joint venture in Delta, B.C., producing high-quality, affordably priced products (1.1 million square feet). Its Emerald Naturals subsidiary has launched a new natural wellness product category with its non-cannabis endocannabinoid-supporting product line and is expanding distribution across Canada.

We seek Safe Harbor.

© 2021 Canjex Publishing Ltd. All rights reserved.